First Foundation Advisors Ionis Pharmaceuticals Inc Transaction History

First Foundation Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$31.71 - $43.0 $720,387 - $976,874	-22,718 Reduced 77.99%	6,412 $237,000
Q1 2022 May 05, 2022	BUY	$29.88 - $37.04 $34,601 - $42,892	1,158 Added 4.14%	29,130 $1.08 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $199,092 - $272,867	-7,774 Reduced 21.75%	27,972 $851,000
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $43,501 - $52,593	1,297 Added 3.76%	35,746 $1.2 Million
Q2 2021 Aug 13, 2021	BUY	$34.54 - $47.25 $151,492 - $207,238	4,386 Added 14.59%	34,449 $1.37 Million
Q1 2021 May 18, 2021	BUY	$42.51 - $63.78 $1.28 Million - $1.92 Million	30,063 New	30,063 $1.35 Million

411

136M

862K

617K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.71B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

Stay updated on First Foundation Advisors with notifications on news.